騰訊(00700.HK)領投卓正醫療E輪戰略融資
據內媒報道,騰訊(00700.HK)領投連鎖醫療服務機構卓正醫療E輪戰略融資,融資總額6,000萬美元,投後估值約40億元人民幣。
報道指,融資過程中,阿里巴巴(09988.HK)、字節跳動也嘗試加入。而騰訊與卓正醫療接觸兩三個月後確認投資,擊敗阿里巴巴、字節跳動。
報道引述某間互聯網公司投資部負責人指,阿里、字節此次跟投未成功,主要是因騰訊投資時有排他性協議。對此消息,騰訊官方並未予以回應,但接近騰訊投資方面人士表示,E輪融資中沒有任何獨家投資協議,而卓正醫療亦有權力選擇投資方,任何投資方都沒權力要求對方做獨家選擇。卓正醫療一方則不予置評。
另外,卓正醫療創始人兼CEO王志遠表示,目前暫無上市計劃且暫不需要再次融資。一方面是目前公司帳面上有超過1億美元現金,資金充裕;二是因為卓正醫療在2017年已實現收支平衡,並在全國8個城市網點實現營利,暫不存在經營壓力。
卓正醫療是一家同時提供線上、線下醫療服務的機構,在北京、上海等國內一二線城市開設30家診所、擁有近300名全職醫生,並提供線上問診、視頻急診、健康管理等服務。服務對象主要是國內中產以上的家庭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.